Gut. 2021 Nov 22:gutjnl-2021-325177. doi: 10.1136/gutjnl-2021-325177. Two microbiota subtypes identified in irritable bowel syndrome with distinct responses to the low FODMAP diet.
Gastroenterology. 2022 Jan;162(1):223-237.e11. doi: 10.1053/j.gastro.2021.09.057. Epithelial X-Box Binding Protein 1 Coordinates Tumor Protein p53-Driven DNA Damage Responses and Suppression of Intestinal Carcinogenesis.
Nat Metab. 2021 Sep;3(9):1150-1162. doi: 10.1038/s42255-021-00440-5. SREBP1-induced fatty acid synthesis depletes macrophages antioxidant defences to promote their alternative activation.
J Crohns Colitis. 2021 Dec 18;15(12):2001-2010. doi: 10.1093/ecco-jcc/jjab093. Long-Term Safety and Efficacy of Risankizumab Treatment in Patients with Crohn’s Disease: Results from the Phase 2 Open-Label Extension Study.
Gut. 2021 Mar 23:gutjnl-2020-323363. doi: 10.1136/gutjnl-2020-323363. Activation of the GPR35 pathway drives angiogenesis in the tumour microenvironment.
Paneth Cell Alertness to Pathogens Maintained by Vitamin D Receptors. Gastroenterology. 2021 Mar;160(4):1269-1283. doi: 10.1053/j.gastro.2020.11.015.
Gastroenterology. 2020 Oct;159(4):1357-1374.e10. doi: 10.1053/j.gastro.2020.06.088. Activating Transcription Factor 6 Mediates Inflammatory Signals in Intestinal Epithelial Cells Upon Endoplasmic Reticulum Stress.
Cell Rep. 2020 Jul 7;32(1):107857. doi: 10.1016/j.celrep.2020.107857. GM-CSF Calibrates Macrophage Defense and Wound Healing Programs during Intestinal Infection and Inflammation.
Macrophage metabolic reprogramming presents a therapeutic target in lupus nephritis. Proc Natl Acad Sci U S A. 2020 Jun 30;117(26):15160-15171. doi: 10.1073/pnas.2000943117.
Nat Commun. 2020 Apr 14;11(1):1775. doi: 10.1038/s41467-020-15646-6. Dietary lipids fuel GPX4-restricted enteritis resembling Crohn’s disease.
Reviews & Editorials
Nat Med. 2021 Nov;27(11):1870-1871. doi: 10.1038/s41591-021-01551-y. Finding the right target for drug-resistant inflammatory bowel disease.
Nat Cell Biol. 2021 Jul;23(7):680-681. doi: 10.1038/s41556-021-00717-7. Prostanoids put a brake on necroptosis in IBD.
Gastroenterology. 2021 Jun;160(7):2247-2249. doi: 10.1053/j.gastro.2021.03.030. Is IL-6 Back in trans Signaling for Inflammatory Bowel Disease?
Nat Rev Dis Primers. 2020 Apr 2;6(1):22. doi: 10.1038/s41572-020-0156-2. Crohn’s disease.
Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol 2010;28:573-621.